| Literature DB >> 25006586 |
Patricia Llorente1, Laura Barnech1, Kinue Irino2, María Valeria Rumi1, Adriana Bentancor1.
Abstract
Consumption of raw/undercooked ground beef is the most common route of transmission of Shiga toxin-producing E. coli (STEC). The aim of the study was to determine the STEC contamination level of the ground beef samples collected in 36 markets of different socioeconomic strata in Buenos Aires, Argentina, and the characterization of the isolated strains. Ninety-one out of 252 (36.1%) samples were stx+. Fifty-seven STEC strains were recovered. Eleven STEC strains belonged to O157 serogroup, and 46 to non-O157 serogroups. Virulence markers of the 57 STEC were stx1, 5.3% (3/57); stx2, 86.0% (49/57); stx1/stx2, 8.8% (5/57); ehxA, 61.4% (35/57); eae, 26.3% (15/57); saa, 24.6% (14/57). Shiga toxin subtypes were stx2, 31.5% (17/54); stx2c-vhb, 24.1% (13/54); stx2c-vha, 20.4% (11/54); stx2/stx2c-vha, 14.8% (8/54); stx2/stx2c-vhb, 5.6% (3/54); stx2c-vha/vhb, 3.7% (2/54). Serotypes O178:H19 and O157:H7 were prevalent. Contamination rate of STEC in all strata was high, and the highest O157 contamination was observed at low strata at several sampling rounds. Persistence of STEC was not detected. Sixteen strains (28.1%) were resistant to ampicillin, streptomycin, amikacin, or tetracycline. The STEC contamination level of ground beef could vary according to the sociocultural characteristics of the population.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25006586 PMCID: PMC4070525 DOI: 10.1155/2014/795104
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Characterization of Shiga toxin-producing E.coli according to their strata, market, and round of sampling.
| Serotype | Virulence profile |
| Strata market (sampling round) | R* | r** |
|---|---|---|---|---|---|
| O2:H25 |
|
| M7 (6) | S | |
| O8:H16 | Ehly, | — | M1 (5) | s | |
| O8:H19 | Ehly, |
| M4 (2) | ||
| O15:H27 | Ehly, |
| H8 (2) | ||
|
|
| M1 (1) | AMP | s | |
| O26:H11 |
| — | M7 (6) | ||
| O79:H19 | Ehly, |
| L6 (2) | ||
| Ehly, |
| L11 (4) | |||
| O82:H8 | Ehly, |
| L8 (7) | S, AK | amp, cn, na, te, f |
| O113:H21 | Ehly, |
| H11 (3) | s | |
|
|
| M7 (3) | s | ||
| O130:H11 | Ehly, |
| L3 (4) | s | |
| O153:H21 | Ehly, |
| H8 (3) | s | |
| O156:NM |
|
| H1 (2) | AMP | |
| O157:H7 | Ehly, |
| L9 (5) | na | |
| Ehly, |
| H10 (2) | AMP | ||
|
| L1 (7); L7 (1) | ||||
|
|
| L5 (7) | te | ||
|
| M12 (2)**** | ||||
|
| M2 (7)**** | S, TE | |||
| M12 (7)**** | S | te | |||
| L9 (6) | s | ||||
|
| M2 (5)**** | ||||
| O157:NM | Ehly, |
| M1 (2) | ||
| O174:H21 |
|
| M11 (4) | s | |
|
| L3 (3); L12 (5) | ||||
| O174:H28 | Ehly, |
| M11 (4) | s | |
| O178:H19 | Ehly, |
| H10 (1) | s | |
| Ehly, |
| M9 (1) | |||
|
| H7 (3) | ||||
|
|
| M6 (1) | |||
|
|
| H1 (1) | |||
|
| H4 (2); M10 (5); L1 (2) | AMP | s | ||
| M2 (4); M11 (4) | s | ||||
|
| M7 (1) | AMP | s | ||
| H5 (1); L7 (3) | s | ||||
| O179:H8 | Ehly, |
| L9 (3) | s | |
| ONT:H7 |
|
| M10 (1) | S | |
|
|
| L10 (1) | |||
|
| H6 (6) | S | ak | ||
| ONT:H8 | Ehly, |
| L3 (2) | AMP | s |
|
|
| M7 (2) | |||
|
| M2 (4) | ||||
| ONT:H19 | Ehly, |
| L1 (7) | S | te |
|
|
| M8 (6) | amp, s | ||
| ONT:H21 | Ehly, |
| L3 (1) | ||
| ONT:H46 | Ehly, |
| M4 (5) | amp, s | |
| ONT:NM |
|
| H11 (1) | ||
|
| L1 (3) | ||||
| OR:NM | Ehly, | — | M2 (2) | ||
| ND | Ehly, |
| H1 (7) | S | te |
AMP, amp: ampicillin; AK, ak: amikacin; S, s: streptomycin; cn: gentamicin; Te, te: tetracycline; na: nalidixic acid; f: nitrofurantoin.
Socioeconomic strata: H: high, M: medium, L: low.
*R: antimicrobial resistance.
**r: reduced susceptibility.
***Mucus-activatable stx2d variant (Zheng et al. 2008) [10].
****Strains from different sampling rounds in the same markets (M2 (5, 7) and M12 (2, 7)) belonging to the same serotype showed differences by subtyping and antibiotyping.
Distribution, according to the different socioeconomic strata, of virulence markers and antimicrobial susceptibility patterns of Shiga toxin-producing Escherichia coli isolated from ground beef in Buenos Aires, Argentina.
| Strata | Proportion of STEC | Genotype | Phenotype | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| Serogroup | Antimicrobial susceptibility* | EHEC-Hly** | ||||||
|
|
|
|
|
|
| O157 | Non-O157*** | S | R | R and r | r |
| ||
|
|
|
|
|
|
| |||||||||
| High | 13/77 | 0 | 2 | 11 | 1 | 4 | 7 | 1 | 12 | 4 | 2 | 3 | 4 | 7 |
| Media | 25/91 | 3 | 1 | 21 | 8 | 3 | 15 | 5 | 20 | 10 | 3 | 4 | 8 | 7 |
| Low | 19/84 | 0 | 2 | 17 | 6 | 7 | 13 | 5 | 14 | 9 | 0 | 4 | 6 | 11 |
|
| ||||||||||||||
| Total | 57/252 | 3 | 5 | 49 | 15 | 14 | 35 | 11 | 46 | 23 | 5 | 11 | 18 | 25 |
*Susceptibility patterns: S: susceptible, R: resistant, r: intermediate or reduced susceptible strains.
**The alfa-hemolytic strain belonging to media strata is not included.
***Non-O157 include serogroups OR and ONT.